INDEPENDENT AUDITORS' CONSENT
Published on January 8, 1999
EXHIBIT 23(c)
Independent Auditors' Consent
The Board of Directors
ACCESS Pharmaceuticals, Inc.
We consent to the use of our report included herein and to
the reference to our firm under the heading "Experts" in the
prospectus.
/s/ Smith Anglin & Co.
- -----------------------
Smith Anglin & Co.
Dallas, Texas
Janaury 8, 1999